The effect of the heterogeneity variance estimator on some tests of treatment efficacy

Journal of Biopharmaceutical Statistics

Volumn 14, Issue 2, 2004, Pages 439-449

  Makambi, Kepher H ^a  

^a HOWARD UNIVERSITY CANCER CENTER   (United States)

Author keywords

Attained significance levels; Overall treatment effect; Random effects model

Indexed keywords

CISAPRIDE;

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG EFFICACY; DYSPEPSIA; HETEROGENEITY VARIANCE ESTIMATOR; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROBABILITY; RISK; STATISTICAL ANALYSIS; STATISTICAL CONCEPTS; STATISTICAL MODEL;

META-ANALYSIS; MODELS, THEORETICAL;

EID: 2642542398     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-120037191     Document Type: Article

References (22)

1. Agresti, A., Hartzel, J. (2000). Strategies for comparing treatments on a binary response with multi-centre data. Statist. Med. 19:1115-1139.
2. Biggerstaff, B. J., Tweedie, R. L. (1997). Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis. Statist. Med. 16:753-768.
3. Boeckenhoff, A., Hartung, J. (1998). Some corrections of the significance level in meta-analysis. Biometrical J. 40:937-947.
4. Brown, H. K., Kempton, R. A. (1994). The application of REML in clinical trials. Statist. Med. 13:1601-1617.
5. Cochran, W. G. (1954). The combination of estimates from different experiments. Biometrics 10:101-129.
6. DerSimonian, R., Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clin. Trials 7:177-188.
7. Grizzle, J. E. (1987). Letter to the editor. Controlled Clin. Trials 8:392-393.
8. Hardy, R. J., Thompson, S. G. (1996). A likelihood approach to meta-analysis with random effects. Statist. Med. 15:619-629.
9. Hartung, J. (1999). An alternative method for meta-analysis. Biometrical J. 41:901-916.
10. Hartung, J., Makambi, K. H. (2000). Positive Estimation of the Between-Study Variance Components in One-Way Anova and Meta-Analysis. Technical report No. 45; Germany: Department of Statistics, University of Dortmund, (also to appear in the South African Statistical Journal).
11. Hartung, J., Knapp, G. (2001). On tests of the overall treatment effect in meta-analysis with normally distributed responses. Statist. Med. 20:1771-1782.
12. Hartung, J., Makambi, K. H. (2001). Simple non-interative t-distribution based tests for meta-analysis. S. Afr. Statist. J. 35:1-17.
13. Higgins, J. P., Whitehead, A. (1996). Borrowing strengths from external trials in a meta analysis. Statist. Med. 15:2733-2749.
14. Li, Y., Shi, L., Roth, H. D. (1994). The basis of commonly-used estimates of variance in meta-analysis. Commun. Statist. Theo. Meth. 23:1063-1085.
15. Makambi, K. H. (2001). Contributions to Inference in the Meta-Analysis of Clinical and Epidemiological Studies. Goettingen: Curvillier Verlag.
16. Mengersen, K. L., Tweedie, R. L., Biggerstaff, B. (1995). The impact of method choice on meta-analysis. Aust. J. Statist. 37(1):19-44.
17. Normand, S.-L. (1999). Meta-analysis: Formulating, evaluating, combining, and reporting. Statist. Med. 18:321-359.
18. Peto, R. (1987). Why do we need systematic overviews of randomized trials? Statist. Med. 6:233-240.
19. Raghunathan, T. E., Yoichi, I. (1993). Analysis of binary data from a multicentre clinical trial. Biometrika 80:127-139.
20. Rao, C. R. (1972). Estimation of variance and covariance components in linear model. J. Amer. Statist. Assoc. 67:112-115.
21. Whitehad, A., Whitehad, J. (1991). A general parametric approach to meta-analysis of randomized clinical trials. Statist. Med. 10:1665-1677.
22. Whitehead, A. (2002). Meta-Analysis of Controlled Clinical Trials. Chichester: Wiley and Sons.